Literature DB >> 16893327

Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness.

J Bryan Page1, Paul Shapshak, E Margarita Duran, Gaelle Even, Irina Moleon-Borodowski, Renee Llanusa-Cestero.   

Abstract

Links between AIDS and self-injection of drugs were first recognized more than 20 years ago, but identification of a specific pathogen and ways to neutralize it has not led to complete success in preventing transmission of HIV-1 infection among injecting drug users (IDUs). A street ethnographer identified active risk locales (places where IDUs go to inject drugs) and recruited their proprietors into a study of contaminated injection paraphernalia. Collected paraphernalia from locales were analyzed for contamination by HIV-1 using real-time polymerase chain reaction (PCR). Proprietors and clientele of 16 risk locales participated by contributing used paraphernalia and/or agreeing to a blood test (0.5-1 mL drawn by finger stick). Realtime PCR was the primary measure used to determine contamination of injection paraphernalia and blood samples with HIV-1. Of 130 samples collected at baseline, a total of 8 were found to have evidence of HIV-1 contamination by detection of either HIV-1 RNA or DNA. The most serious contamination (up to 600,000 copies per milliliter) was found in ancillary paraphernalia, rather than needle/syringe (N/S) specimens. Only 4 of 74 N/S specimens had any evidence of HIV-1 contamination at all (with very low viral loads), and none had both HIV-1 DNA and RNA. Although IDUs in risk locales in Miami/Dade appear to be taking care of their N/S with regard to contamination by HIV-1, important evidence of contamination in ancillary paraphernalia, especially cookers and cottons, indicates that IDUs may still incur serious risk regardless of how well they care for their N/S. Our observations indicated that IDUs rinsed their N/S before returning them to the proprietors, from whom we eventually collected them, and this rinsing would have masked the contamination to which they were exposed through use of unrinsed cookers and reused cottons.

Entities:  

Mesh:

Year:  2006        PMID: 16893327     DOI: 10.1089/apc.2006.20.576

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  6 in total

1.  Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network.

Authors:  Daniel J Pilowsky; Li-Tzy Wu; Bruce Burchett; Dan G Blazer; Walter Ling
Journal:  Subst Use Misuse       Date:  2011-10-05       Impact factor: 2.164

2.  Longitudinal analysis of the relationship between perceived norms and sharing injection paraphernalia.

Authors:  Melissa A Davey-Rothwell; Carl A Latkin; Karin E Tobin
Journal:  AIDS Behav       Date:  2009-01-16

3.  Predictors of sharing injection equipment by HIV-seropositive injection drug users.

Authors:  Carl A Latkin; Amy S Buchanan; Lisa R Metsch; Kelly Knight; Mary H Latka; Yuko Mizuno; Amy R Knowlton
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

Review 4.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Heating Injection Drug Preparation Equipment Used for Opioid Injection May Reduce HIV Transmission Associated With Sharing Equipment.

Authors:  Laura J Ball; Colin Venner; Rommel G Tirona; Eric Arts; Kaveri Gupta; Joshua C Wiener; Sharon Koivu; Michael S Silverman
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

6.  Sharing of Injection Drug Preparation Equipment Is Associated With HIV Infection: A Cross-sectional Study.

Authors:  Laura J Ball; Klajdi Puka; Mark Speechley; Ryan Wong; Brian Hallam; Joshua C Wiener; Sharon Koivu; Michael S Silverman
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.